AFYCX
Price
$25.54
Change
+$0.13 (+0.51%)
Updated
Jul 3 closing price
Net Assets
1.86B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

AFYCX vs VIVAX

Header iconAFYCX vs VIVAX Comparison
Open Charts AFYCX vs VIVAXBanner chart's image
Bahl & Gaynor Income Growth C
Price$25.54
Change+$0.13 (+0.51%)
VolumeN/A
Net Assets1.86B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
AFYCX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AFYCX vs. VIVAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFYCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. AFYCX (1.86B). VIVAX pays higher dividends than AFYCX: VIVAX (2.06) vs AFYCX (0.94). AFYCX was incepted earlier than VIVAX: AFYCX (12 years) vs VIVAX (33 years). AFYCX (1.60) is less costly to investors than VIVAX (0.17). AFYCX is a more actively managed with annual turnover of: 12.00 vs. VIVAX (9.00). AFYCX has a lower initial minimum investment than VIVAX: AFYCX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. AFYCX (4.75). VIVAX return over 5 years is better than : 80.14 vs. AFYCX (50.79).
AFYCXVIVAXAFYCX / VIVAX
Total Expense Ratio1.600.17941%
Annual Report Gross Expense Ratio1.600.17941%
Fund Existence12 years33 years-
Gain YTD4.8786.20979%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.86B189B1%
Annual Yield % from dividends0.942.0645%
Returns for 1 year4.7512.0439%
Returns for 3 years21.3235.1661%
Returns for 5 years50.7980.1463%
Returns for 10 years111.62115.7496%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.